Literature DB >> 9578162

The effect of antifungal drugs in combination on the growth of Candida glabrata in solid and liquid media.

H Siau1, D Kerridge.   

Abstract

The effect of drugs in combination on the growth of Candida glabrata was studied in solid medium by demonstration of reduced or enhanced growth, and in liquid medium by determination of interaction indices. Amphotericin B and 5-fluorocytosine showed a synergic effect, while combinations of amphotericin B and miconazole, and miconazole and 5-fluorocytosine exhibited antagonistic effects. In addition, concentration-dependent antagonism was observed amongst combinations of metabolic inhibitors, between inhibitors of sterol biosynthesis (terbinafine, miconazole, ketoconazole, clotrimazole, econazole, fluconazole, itraconazole and amorolfine) and inhibitors of nucleic acid or protein biosynthesis (5-fluorocytosine, 5-fluorouracil, rifampicin and chlortetracycline). This antagonism was strain-specific, occurring with C. glabrata strain 4, Saccharomyces cerevisiae strain 237 and Candida albicans strain 72R, but not with C. albicans strain 6406 or Candida parapsilosis strain 3104.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9578162     DOI: 10.1093/jac/41.3.357

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

Review 1.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

2.  Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.

Authors:  K W Henry; M C Cruz; S K Katiyar; T D Edlind
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

3.  Effects of antifungal agents alone and in combination against Candida glabrata strains susceptible or resistant to fluconazole.

Authors:  Izabel Almeida Alves; Laíssa Arévalo Bandeira; Débora Alves Nunes Mario; Laura Bedin Denardi; Louise Vignoles Neves; Janio Morais Santurio; Sydney Hartz Alves
Journal:  Mycopathologia       Date:  2012-04-22       Impact factor: 2.574

Review 4.  Antifungal combination therapy: clinical potential.

Authors:  John W Baddley; Peter G Pappas
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Multicenter prospective observational study of fungal keratitis in Japan: analyses of in vitro susceptibility tests for combinations of drugs.

Authors:  Keigo Kimura; Yoshitsugu Inoue; Seishi Asari; Atsuko Sunada; Yuichi Ohashi; Yoshikazu Shimomura; Chie Sotozono; Hiroshi Hatano; Masahiko Fukuda; Hiroshi Eguchi; Kaoru Araki-Sasaki; Takashi Suzuki; Saichi Hoshi; Toru Tobe; Takashi Yaguchi; Koichi Makimura
Journal:  Jpn J Ophthalmol       Date:  2022-03-29       Impact factor: 2.447

6.  Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi.

Authors:  Brian G Oliver; Peter M Silver; Chelsea Marie; Samantha J Hoot; Sarah E Leyde; Theodore C White
Journal:  Microbiology       Date:  2008-03       Impact factor: 2.777

7.  Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter.

Authors:  Thierry Noël; Fabienne François; Patrick Paumard; Christiane Chastin; Daniel Brèthes; Jean Villard
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

8.  Flucytosine antagonism of azole activity versus Candida glabrata: role of transcription factor Pdr1 and multidrug transporter Cdr1.

Authors:  Zoë Steier; John-Paul Vermitsky; Geoffrey Toner; Scott E Gygax; Thomas Edlind; Santosh Katiyar
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

9.  In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus.

Authors:  Eric Dannaoui; Olivier Lortholary; Françoise Dromer
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

10.  Clinical efficacy and health implications of inconsistency in different production batches of antimycotic drugs in a developing country.

Authors:  Adenike A O Ogunshe; Adedayo A Adepoju; Modupe E Oladimeji
Journal:  J Pharm Bioallied Sci       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.